论文部分内容阅读
目的:分析血塞通联合前列地尔治疗慢性肾小球肾炎的临床疗效,总结临床治疗的最佳方案。方法:共收录2012年11月-2013年11月,30例于我院肾内科接受治疗的慢性肾小球肾炎患者的资料,对其临床治疗情况回顾性分析。对30例分组处理,分为观察组、对照组,每组15例;对照组采用常规治疗法,单一使用前列地尔;观察组采用联合治疗法,血塞通片+前列地尔;治疗后60d,对比2组的症状情况。结果:经过30例临床回访调查,观察组治疗效果明显优于对照组,在水肿、血压、肾功能等方面治疗差异显著(P<0.01)。结论:血塞通联合前列地尔治疗慢性肾小球肾炎效果显著,临床需积极推广。
Objective: To analyze the clinical efficacy of Xuesaitong combined with alprostadil in the treatment of chronic glomerulonephritis and to summarize the best clinical treatment plan. Methods: A total of 30 patients with chronic glomerulonephritis who were treated in Department of Nephrology of our hospital from November 2012 to November 2013 were retrospectively analyzed. Thirty cases were divided into observation group and control group, 15 cases in each group. The control group received routine treatment and single-use alprostadil. The observation group received combination therapy and Xuesaitong tablets plus alprostadil. After treatment, 60d, compared with 2 groups of symptoms. Results: After 30 cases of clinical follow-up survey, the observation group was significantly better than the control group, with significant differences in edema, blood pressure and renal function (P <0.01). Conclusion: Xuesaitong combined with alprostadil treatment of chronic glomerulonephritis significant effect, the need to actively promote the clinical.